Are you looking for underappreciated growth stocks that can deliver big gains? Try starting your search in the rapidly growing industry for minimally invasive cosmetic procedures.

The global market for noninvasive aesthetic treatments reached $61.2 billion in 2022 and is expected to grow by 15.4% annually through 2030. With minimally invasive skin-sculpting tools that produce results similar to liposuction, InMode (NASDAQ: INMD) is well positioned to ride this trend.

This medical device maker keeps reporting impressive growth on both its top and bottom lines, but the stock market hasn't seemed to notice. Right now, you can buy it at prices that look like an unbeatable bargain.

Continue reading

Source Fool.com